Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
Rhee TG, Shim SR, Forester BP, Nierenberg AA, McIntyre RS, Papakostas GI, Krystal JH, Sanacora G, Wilkinson ST.
JAMA Psychiatry. 2022 Dec 1;79(12):1162-1172. doi: 10.1001/jamapsychiatry.2022.3352.
Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial.
Leffa DT, Grevet EH, Bau CHD, Schneider M, Ferrazza CP, da Silva RF, Miranda MS, Picon F, Teche SP, Sanches P, Pereira D, Rubia K, Brunoni AR, Camprodon JA, Caumo W, Rohde LA.
JAMA Psychiatry. 2022 Sep 1;79(9):847-856. doi: 10.1001/jamapsychiatry.2022.2055.
Home-based transcranial direct current stimulation in bipolar depression: an open-label treatment study of clinical outcomes, acceptability and adverse events.
Ghazi-Noori AR, Woodham RD, Rezaei H, Sharif MS, Bramon E, Ritter P, Bauer M, Young AH, Fu CHY.
Int J Bipolar Disord. 2024 Aug 20;12(1):30. doi: 10.1186/s40345-024-00352-9.
Prevalence of cognitive impairment in major depression and bipolar disorder.
Douglas KM, Gallagher P, Robinson LJ, Carter JD, McIntosh VV, Frampton CM, Watson S, Young AH, Ferrier IN, Porter RJ.
Bipolar Disord. 2018 May;20(3):260-274. doi: 10.1111/bdi.12602. Epub 2018 Jan 18.
Predictors of switch from depression to mania in bipolar disorder.
Niitsu T, Fabbri C, Serretti A.
J Psychiatr Res. 2015 Jul-Aug;66-67:45-53. doi: 10.1016/j.jpsychires.2015.04.014. Epub 2015 Apr 22.
Enhanced network synchronization connectivity following transcranial direct current stimulation (tDCS) in bipolar depression: Effects on EEG oscillations and deep learning-based predictors of clinical remission.
Xiao W, Moncy JC, Ghazi-Noori AR, Woodham RD, Rezaei H, Bramon E, Ritter P, Bauer M, Young AH, Fu CHY.
J Affect Disord. 2025 Jan 15;369:576-587. doi: 10.1016/j.jad.2024.09.054. Epub 2024 Sep 16.
Fast depressive symptoms improvement in bipolar I disorder after Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT): A two-site feasibility and safety open-label trial.
Li K, Bichlmeier A, DuPont C, Siegel-Ramsay JE, Comfort A, Logue E, Stimpson KH, Bentzley B, Williams N, Reti I, Almeida J, Zandi P.
J Affect Disord. 2024 Nov 15;365:359-363. doi: 10.1016/j.jad.2024.08.087. Epub 2024 Aug 16.
EEG alpha band characteristics in patients with a depressive episode within recurrent and bipolar depression.
Bokhan NA, Galkin SA, Vasilyeva SN.
Consort Psychiatr. 2023 Sep 29;4(3):5-12. doi: 10.17816/CP6140.
Lurasidone for the treatment of bipolar depression: an evidence-based review.
Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T.
Neuropsychiatr Dis Treat. 2015 Aug 19;11:2143-52. doi: 10.2147/NDT.S50961. eCollection 2015.
Bipolar disorder treatment according to illness trajectory: a systematic review of clinical trials.
Marchionatti LE, Antonelli-Salgado T, Erthal IN, Lopes SLS, Lucas LS, Rebouças DB, Passos IC.
Psychiatry Res. 2022 Jun;312:114572. doi: 10.1016/j.psychres.2022.114572. Epub 2022 Apr 25.
